CORE TABLET FOR CONTROLLED RELEASE OF GLICLAZIDE AFTER ORAL ADMINISTRATION

摘要

The invention relates to a matrix tablet for the prolonged release of gliclazide which ensures continuous and consistent release of the active ingredient after administration by the oral route, the release being insensitive to variations in the pH of the dissolution medium.